BRIGHT-4: Large, 'Clean' Trial Clarifies Bivalirudin Benefits in STEMI
Experts say it’s likely too late for cath labs to stomach a bolus plus infusion, having turned back to heparin once and for all.
Source: tctmd.com
Stay updated with breaking news from Nail Out. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts say it’s likely too late for cath labs to stomach a bolus plus infusion, having turned back to heparin once and for all.